Back to Search
LINDA WELLES, MD
MD
Geriatric Medicine (Internal Medicine) Physician
NPI: 1326014366Individual
Specialties, Licenses & Credentials
Geriatric Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Geriatric Medicine
Code: 207RG0300X
244687(NY)
Research & Publications (9)
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
PMID 19433391·Clin Breast Cancer·2009
3-trial
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.
PMID 16879771·Clin Lymphoma Myeloma·2006
3-trial
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
PMID 15226333·J Clin Oncol·2004
3-trial
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer.
PMID 12634619·Anticancer Drugs·2003
3-trial
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy.
PMID 12472371·Expert Opin Pharmacother·2002
4-observational
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
PMID 11815957·Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 84 CANAL ST
BIG FLATS, NY 14814 - Phone
- (607) 301-4141
Quick Facts
- NPI
- 1326014366
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile